5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.77▲ | 0.77▲ | 0.77▲ | 0.72▲ | 0.79▼ |
MA10 | 0.76▲ | 0.76▲ | 0.74▲ | 0.71▲ | 0.71▲ |
MA20 | 0.72▲ | 0.72▲ | 0.71▲ | 0.76▲ | 0.73▲ |
MA50 | 0.75▲ | 0.77▲ | 0.78▲ | 0.70▲ | 1.14▼ |
MA100 | 0.80▼ | 0.81▼ | 0.78▲ | 0.73▲ | 1.32▼ |
MA200 | 0.82▼ | 0.73▲ | 0.70▲ | 0.97▼ | 1.53▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.011▲ | 0.013▲ | 0.015▲ | -0.003▼ | 0.042▲ |
RSI | 66.711▲ | 62.705▲ | 61.527▲ | 58.099▲ | 47.838▼ |
STOCH | 89.393▲ | 89.997▲ | 93.219▲ | 39.558 | 54.103 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -44.394 | -41.902 |
CCI | 96.389 | 95.611 | 121.440▲ | 82.176 | 50.464 |
Friday, August 08, 2025 02:00 PM
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX), a clinical-stage biotechnology company advancing T cell-engaging bispecific antibodies for solid tumors, reported a second-quarter net loss ...
|
Wednesday, August 06, 2025 01:21 PM
CTIM-76 and CT-95 Phase 1 dose-escalation studies ongoing Cash and cash equivalents of $83.5 million as of June 30, 2025 Company expects its cash and cash equivalents will continue to fund operations ...
|
Friday, July 25, 2025 05:22 AM
Context Therapeutics Inc. (NASDAQ: CNTX) is one of the best penny stocks under $1 to buy now. Earlier in June, Context Therapeutics presented a Trial in Progress poster for its Phase 1 clinical ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 0.769 | 0.7995 | 0.7505 | 0.7863 | 178,296 |
14/08/25 | 0.71 | 0.7399 | 0.70 | 0.7363 | 94,960 |
13/08/25 | 0.6837 | 0.7099 | 0.677 | 0.70 | 248,065 |
12/08/25 | 0.70 | 0.705 | 0.6772 | 0.68 | 77,918 |
11/08/25 | 0.73 | 0.73 | 0.6755 | 0.6772 | 95,175 |
08/08/25 | 0.69 | 0.7198 | 0.6798 | 0.7198 | 116,146 |
07/08/25 | 0.7046 | 0.72 | 0.6815 | 0.699 | 84,163 |
06/08/25 | 0.70 | 0.72 | 0.69 | 0.699 | 47,393 |
05/08/25 | 0.70 | 0.7149 | 0.6801 | 0.70 | 104,124 |
04/08/25 | 0.728 | 0.728 | 0.6752 | 0.68 | 184,951 |
|
|
||||
|
|
||||
|
|